CCL20, on the other hand, is over-expressed in esophageal carcinoma, and it has been shown to have a poor prognosis when its expression increases; in general, a crucial role of CCL20 has been demonstrated in tumor malignancy. This evidence concerns the gene CCL20 and neoplasm.